GPER1 and breast carcinoma: Moreover, EGFR ligands were shown to up-regulate GPER expression by activating the EGFR/ERK transduction pathway in ER-positive tamoxifen-resistant breast cancer cells, indicating that the activation of EGFR signaling may contribute to tamoxifen resistance at least in part by up-regulating GPER expression (45).